Hollow Fiber Dialyzer Sales

Hollow Fiber Dialyzer Sales Market Outlook

The global Hollow Fiber Dialyzer Market is projected to reach approximately USD 6.6 billion by 2035, growing at a CAGR of around 8% during the forecast period of 2025 to 2035. This growth is primarily driven by the rising prevalence of chronic kidney diseases (CKD) and the increasing demand for effective renal replacement therapies. As the aging population continues to expand, the incidence of renal disorders is anticipated to rise, subsequently leading to an increased requirement for advanced dialysis solutions. Furthermore, innovations in dialyzer technologies and materials have enabled improved efficiency and patient outcomes, catalyzing market growth. The expansion of healthcare infrastructure coupled with favorable reimbursement policies in various regions is also expected to contribute to a robust market environment.

Growth Factor of the Market

The growth of the Hollow Fiber Dialyzer Market is fueled by several key factors that intersect to create a fertile landscape for expansion. One of the most significant drivers is the escalating incidence of chronic kidney diseases, which has led to heightened demand for hemodialysis procedures and advanced dialyzer technologies. Moreover, technological advancements in dialyzer design, such as enhanced biocompatibility and reduced blood compatibility issues, are making these devices more effective and safer for patients. The increasing awareness regarding the benefits of early diagnosis and treatment of kidney ailments is also playing a pivotal role in market growth, as it leads to higher adoption rates of dialysis therapies. Additionally, the surge in healthcare expenditure and evolving reimbursement policies are helping to alleviate financial burdens on patients, making dialysis more accessible. Lastly, the rise in numerous dialysis centers and clinics worldwide is further propelling the market as they serve as critical points for delivering these essential healthcare services.

Key Highlights of the Market

• The global hollow fiber dialyzer market is expected to reach USD 6.6 billion by 2035.
• The market is growing at a CAGR of around 8% during the forecast period of 2025-2035.
• Technological advancements are leading to improved dialyzer efficiency and patient outcomes.
• Rising incidences of chronic kidney diseases are increasing demand for effective dialysis solutions.
• The expansion of healthcare infrastructure is facilitating greater access to dialysis treatments.

By Product Type

Low-Flux Dialyzers:

Low-flux dialyzers are designed to remove small solutes from the blood, making them particularly suitable for patients with stable renal failure who do not require high rates of fluid removal. The market for low-flux dialyzers is witnessing steady growth, primarily due to their affordability and widespread availability. These dialyzers are often chosen for patients undergoing long-term hemodialysis, as they encourage more gradual and controlled treatment processes. Additionally, advancements in material sciences have improved the efficiency of low-flux dialyzers, allowing for enhanced performance over traditional options, thus catering to the needs of a broader range of patients.

High-Flux Dialyzers:

High-flux dialyzers are designed to facilitate the removal of both small and larger solutes, making them an optimal choice for patients with advanced renal failure who need more aggressive treatment. The increasing adoption of high-flux dialyzers is attributed to their ability to provide better clearance of uremic toxins and a reduction in treatment time for patients. This segment is anticipated to experience significant growth due to ongoing studies highlighting the benefits of high-flux dialysis in improving patient outcomes, including reduced hospitalizations and enhanced quality of life. Moreover, the introduction of innovative designs and materials continues to drive market interest in high-flux dialyzers, catering to the evolving needs of healthcare providers.

Medium-Cut-Off Dialyzers:

Medium-cut-off dialyzers represent a hybrid approach between low-flux and high-flux options, allowing for selective removal of middle molecules. This product type is gaining traction as it provides an intermediate solution for patients needing more effective dialysis without the risks associated with high-flux treatments. Their growing acceptance in clinical practice is supported by emerging evidence suggesting that they can improve outcomes for certain patient populations. The medium-cut-off dialyzers are particularly beneficial for patients who exhibit symptoms of inflammation, as they help in clearing inflammatory mediators from the bloodstream. The market for this segment is anticipated to expand as more clinicians recognize the advantages of using medium-cut-off technologies.

High-Cut-Off Dialyzers:

High-cut-off dialyzers are innovative devices specifically designed to remove larger solutes and middle molecules. They have gained importance in treating patients with specific conditions, such as chronic kidney disease and certain forms of renal replacement therapy. This segment is expected to see substantial growth as healthcare providers increasingly recognize the benefits associated with high-cut-off dialysis, including improved management of chronic inflammation and better overall patient outcomes. The rising prevalence of conditions necessitating high-cut-off dialysis, along with advancements in dialyzer manufacturing processes, continues to increase the market's attractiveness for this product type, paving the way for broader clinical adoption.

Hemodialyzers:

Hemodialyzers are a fundamental component of the dialysis process, acting as artificial kidneys that filter the blood. The demand for hemodialyzers is continually rising, driven by the growing prevalence of end-stage renal disease (ESRD) and the expanding number of dialysis treatments performed globally. Technological innovations in hemodialyzers, including enhanced membrane technology and biocompatibility features, have significantly improved treatment efficacy and patient comfort. As healthcare systems evolve and prioritize the optimization of renal replacement therapies, the hemodialyzer segment is expected to experience robust growth, fueled by advancements in design and a greater focus on patient-centered care.

By Application

Hemodialysis:

Hemodialysis is the most common application for hollow fiber dialyzers, where blood is filtered through dialyzers to remove waste products and excess fluids. The rising prevalence of chronic kidney diseases, along with an increasing elderly population, drives demand for effective hemodialysis solutions. Continuous advancements in dialysis technology and an increase in healthcare expenditure worldwide are contributing to a positive outlook for this application segment. Moreover, the establishment of specialized dialysis centers and a growing awareness of the importance of regular dialysis sessions among patients are further bolstering the hemodialysis market.

Peritoneal Dialysis:

Peritoneal dialysis is another significant application of hollow fiber dialyzers, providing an alternative renal replacement therapy for patients who are unable to undergo hemodialysis. This application is gaining traction due to its advantages, including greater flexibility and the potential for home-based treatment. The increasing number of patients opting for peritoneal dialysis, due to lifestyle preferences and personalized treatment options, is driving market growth. Additionally, innovations in peritoneal dialysis solutions and improved training programs for patients and caregivers are enhancing the effectiveness and safety of this application.

Liver Dialysis:

Liver dialysis remains a niche but growing application of hollow fiber dialyzers, used primarily in patients with acute liver failure or severe liver dysfunction. This segment is witnessing gradual growth, driven by increasing awareness of liver diseases and their associated complications. As the healthcare community recognizes the importance of timely intervention in liver failure cases, the demand for specialized dialysis techniques continues to rise. Additionally, clinical advancements in liver dialysis technologies are paving the way for improved treatment efficacy, fostering greater acceptance among healthcare providers and leading to better patient outcomes.

Others:

The "Others" category encompasses various alternative applications of hollow fiber dialyzers that may not fit neatly into traditional classifications. This segment is characterized by innovative uses of dialyzer technology, encompassing research applications and specialized therapies tailored for unique patient populations. The growth of this segment is driven by ongoing research and development efforts aimed at expanding the utility of hollow fiber dialyzers. As medical professionals continue to explore new applications, the "Others" category is expected to gain momentum, contributing to the overall market growth.

By Distribution Channel

Hospitals:

Hospitals are one of the primary distribution channels for hollow fiber dialyzers, serving as critical healthcare facilities for patients requiring dialysis treatments. The hospital segment is expected to experience continued growth as healthcare systems expand and evolve to address the needs of patients suffering from kidney diseases. Hospitals typically offer a range of services, including hemodialysis and patient education, which contribute to their attractiveness as treatment centers. Moreover, advancements in hospital infrastructure and technology are improving the quality of care, thereby increasing the demand for hollow fiber dialyzers within this distribution channel.

Clinics:

Clinics are increasingly becoming popular distribution channels for hollow fiber dialyzers, especially in outpatient settings. The demand for dialysis services in clinics is driven by the rising preference for more localized healthcare options, allowing patients to receive treatments closer to home. Clinics often offer more flexible scheduling and personalized care, making them an appealing alternative for patients. Additionally, as more clinics incorporate advanced technologies and streamline operations, the attractiveness of this distribution channel continues to rise, further enhancing the market for dialyzer products.

Dialysis Centers:

Dialysis centers are specialized facilities dedicated to providing renal replacement therapies, making them essential distribution channels for hollow fiber dialyzers. The market for dialysis centers is witnessing significant growth due to the increasing prevalence of chronic kidney disease and the need for dedicated treatment environments. These centers typically offer comprehensive support services, including patient education and emotional support, which can enhance the overall patient experience. The establishment of new dialysis centers worldwide, especially in underserved regions, is expected to further drive demand for hollow fiber dialyzers, ensuring that patients have access to essential dialysis treatments.

Others:

The "Others" category includes various distribution channels not classified under hospitals, clinics, or dialysis centers. This segment may encompass retail pharmacies or online platforms where hollow fiber dialyzers can be purchased. Growth in this segment is being driven by the increasing consumer preference for convenient purchasing options and the rising trend of home-based dialysis. As healthcare providers adapt to changing patient preferences and explore alternative distribution methods, the "Others" category is likely to become an increasingly important part of the hollow fiber dialyzer market.

By Material Type

Cellulose-Based:

Cellulose-based hollow fiber dialyzers represent a traditional and widely used category, primarily due to their cost-effectiveness and proven efficacy. These dialyzers utilize cellulose membranes, which effectively filter waste products from the blood while maintaining biocompatibility. The cellulose-based segment is expected to maintain a strong presence in the market, especially among cost-sensitive healthcare providers and patients. However, the introduction of advanced materials and technologies may pose challenges to the growth of this segment as healthcare providers seek more efficient alternatives.

Synthetic Polymer-Based:

Synthetic polymer-based hollow fiber dialyzers are gaining popularity due to their enhanced biocompatibility and filtration efficiency compared to traditional cellulose-based options. The use of synthetic materials allows for finer control over pore sizes, improving solute clearance and minimizing complications. As healthcare providers continue to prioritize patient safety and treatment efficacy, the demand for synthetic polymer-based dialyzers is expected to rise significantly. Innovations in manufacturing processes are further driving advancements in this segment, allowing for tailored solutions that meet the diverse needs of patients.

Regenerated Cellulose-Based:

Regenerated cellulose-based hollow fiber dialyzers combine the benefits of both synthetic and traditional cellulose materials, offering improved performance and biocompatibility. This segment is witnessing notable growth as healthcare providers seek more advanced solutions that enhance patient outcomes without compromising safety. Regenerated cellulose dialyzers can provide superior clearance rates and lower inflammatory responses, making them an attractive choice for dialysis treatment. The increasing focus on patient-centered care is expected to propel the demand for regenerated cellulose-based products as healthcare systems adapt to the evolving landscape of renal replacement therapies.

Others:

The "Others" segment encompasses various innovative materials that may be used in the production of hollow fiber dialyzers, reflecting ongoing research and development efforts in the industry. These materials may include novel composites or hybrid technologies that enhance performance characteristics while addressing specific patient needs. As the healthcare community continues to explore alternative materials, the "Others" category is expected to gain traction, driven by advancements in material science and the search for more effective treatment modalities.

By Region

The North America region is a significant player in the Hollow Fiber Dialyzer Market, accounting for approximately 38% of the global market share in 2025. This dominance can be attributed to the high prevalence of chronic kidney diseases, the presence of advanced healthcare infrastructure, and a well-established reimbursement framework for dialysis therapies. Additionally, ongoing research and clinical trials in the region have led to innovations in dialyzer technology, further enhancing treatment options for patients. The CAGR for North America is projected to be around 7% during the forecast period, driven by increasing investments in healthcare and a growing emphasis on improving patient outcomes.

Europe is another key market for hollow fiber dialyzers, contributing around 30% to the global market share in 2025. The region is experiencing significant growth, bolstered by an aging population, increasing incidences of kidney-related ailments, and a growing number of specialized dialysis centers. Advances in technology and ongoing collaborations between healthcare providers and manufacturers are driving innovation within the European market. The CAGR for Europe is expected to be approximately 6.5% over the forecast period, as governments implement supportive healthcare policies and improve access to dialysis treatments.

Opportunities

The Hollow Fiber Dialyzer Market presents numerous opportunities for growth, particularly as healthcare systems globally shift toward innovative renal replacement therapies to address the rising burden of chronic kidney disease. One of the most significant opportunities lies in the increased focus on home-based dialysis solutions. As patients seek greater convenience and autonomy in their treatment options, healthcare providers are pushed to develop and supply products that facilitate at-home dialysis. This trend is likely to lead to increased demand for hollow fiber dialyzers that cater specifically to the requirements of home dialysis patients, effectively expanding market reach. Furthermore, the continued advancements in dialyzer technology and materials offer companies the chance to differentiate their products, lending themselves to enhanced performance and better patient outcomes.

Another opportunity for growth in the hollow fiber dialyzer market can be found in emerging economies, where the healthcare infrastructure is rapidly developing. As these regions recognize the importance of providing adequate renal care, the demand for effective dialysis solutions is expected to surge. Companies can capitalize on this potential by establishing partnerships with local healthcare providers, thereby ensuring access to their products while also supporting the development of local manufacturing capabilities. Additionally, investment in education and training programs aimed at both healthcare providers and patients can help facilitate the adoption of dialysis therapies, ultimately driving market growth in these underserved regions.

Threats

Despite the positive outlook for the Hollow Fiber Dialyzer Market, several threats could hinder growth and market stability. One potential threat arises from the increasing competition among manufacturers, leading to potential price wars and reduced profit margins. As companies strive to capture market share, they may resort to aggressive pricing strategies that could negatively impact the overall profitability of the sector. Additionally, the healthcare market is subject to stringent regulatory requirements, which can pose challenges for manufacturers in terms of compliance and product approvals. Any changes in regulatory policies could create hurdles for new product introductions and market expansion.

Another significant threat to the hollow fiber dialyzer market is the potential for supply chain disruptions. The ongoing global challenges in logistics, exacerbated by geopolitical tensions and the COVID-19 pandemic, have highlighted vulnerabilities in supply chains across industries. Manufacturers may face difficulties in sourcing raw materials, which could lead to increased production costs and delayed product availability. Such disruptions can have a direct impact on healthcare providers' ability to deliver timely and effective dialysis treatments, thereby affecting patient outcomes. Addressing these challenges will be critical for market players to maintain a competitive edge and ensure a reliable supply of hollow fiber dialyzers.

Competitor Outlook

• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Davita Inc.
• Nipro Corporation
• Asahi Kasei Corporation
• Medtronic PLC
• Gambro AB (part of Baxter)
• Bellco S.R.L.
• Toray Industries, Inc.
• Kawasumi Laboratories, Inc.
• HemoCue AB (part of Radiometer)
• Shenzhen Tsinghua University Technology Co., Ltd.
• DialySys S.A.
• Renal Therapy Services
• STARMED, S.A.

The competitive landscape of the Hollow Fiber Dialyzer Market is characterized by a diverse array of key players, each vying for market share through innovation, strategic partnerships, and the development of advanced technologies. Major companies such as Baxter International Inc. and Fresenius Medical Care AG & Co. KGaA dominate the market, leveraging their extensive product portfolios and established distribution networks. These companies are known for their commitment to research and development, allowing them to introduce cutting-edge dialyzer technologies that cater to the evolving needs of patients and healthcare providers. As the market continues to expand, these industry leaders are likely to invest heavily in new product developments and enhancements, contributing to their competitive advantage.

Davita Inc. and Nipro Corporation are also prominent players in the hollow fiber dialyzer market, recognized for their innovative approaches and robust product offerings. Davita, one of the largest providers of kidney care services, is continuously exploring advanced treatment modalities, including integrated care models that improve patient outcomes. Nipro Corporation, on the other hand, has focused on diversifying its product range and expanding its global presence, particularly in emerging markets. As competition intensifies, these companies are expected to form strategic alliances and partnerships to enhance their market positions and offer comprehensive solutions to healthcare providers.

Additionally, companies like Asahi Kasei Corporation and Medtronic PLC are making significant strides in the development of hollow fiber dialyzer technologies. Asahi Kasei is renowned for its innovative products that enhance biocompatibility and filtration efficiency, while Medtronic is leveraging its expertise in medical devices to create sophisticated solutions for renal replacement therapies. As the industry landscape evolves, these companies will continue to adapt to technological advancements and patient preferences, ensuring their relevance in the competitive market. Overall, the outlook for the hollow fiber dialyzer market remains positive, with significant growth opportunities driven by ongoing innovations and an increasing focus on improving patient care.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Davita Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Bellco S.R.L.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 DialySys S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic PLC
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 STARMED, S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Nipro Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Renal Therapy Services
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Toray Industries, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Asahi Kasei Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Baxter International Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Gambro AB (part of Baxter)
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Kawasumi Laboratories, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 HemoCue AB (part of Radiometer)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fresenius Medical Care AG & Co. KGaA
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Shenzhen Tsinghua University Technology Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Hollow Fiber Dialyzer Sales Market, By Application
    • 6.1.1 Hemodialysis
    • 6.1.2 Peritoneal Dialysis
    • 6.1.3 Liver Dialysis
    • 6.1.4 Others
  • 6.2 Hollow Fiber Dialyzer Sales Market, By Product Type
    • 6.2.1 Low-Flux Dialyzers
    • 6.2.2 High-Flux Dialyzers
    • 6.2.3 Medium-Cut-Off Dialyzers
    • 6.2.4 High-Cut-Off Dialyzers
    • 6.2.5 Hemodialyzers
  • 6.3 Hollow Fiber Dialyzer Sales Market, By Material Type
    • 6.3.1 Cellulose-Based
    • 6.3.2 Synthetic Polymer-Based
    • 6.3.3 Regenerated Cellulose-Based
    • 6.3.4 Others
  • 6.4 Hollow Fiber Dialyzer Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Dialysis Centers
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Hollow Fiber Dialyzer Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Hollow Fiber Dialyzer Sales market is categorized based on

By Product Type

• Low-Flux Dialyzers
• High-Flux Dialyzers
• Medium-Cut-Off Dialyzers
• High-Cut-Off Dialyzers
• Hemodialyzers

By Application

• Hemodialysis
• Peritoneal Dialysis
• Liver Dialysis
• Others

By Distribution Channel

• Hospitals
• Clinics
• Dialysis Centers
• Others

By Material Type

• Cellulose-Based
• Synthetic Polymer-Based
• Regenerated Cellulose-Based
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Davita Inc.
• Nipro Corporation
• Asahi Kasei Corporation
• Medtronic PLC
• Gambro AB (part of Baxter)
• Bellco S.R.L.
• Toray Industries, Inc.
• Kawasumi Laboratories, Inc.
• HemoCue AB (part of Radiometer)
• Shenzhen Tsinghua University Technology Co., Ltd.
• DialySys S.A.
• Renal Therapy Services
• STARMED, S.A.